Mutations in the phenylalanine hydroxylase (PAH) gene represent the ro
ot cause of PAH-deficient hyperphenylalaninemia. To date, more than 16
0 different mutations have been reported. Single-base substitutions an
d microdeletions account for the majority of molecular defects. This r
eview provides a brief general introduction to various strategies for
detection of PAH mutations, and summarizes our own methodological deve
lopments. We have established a method based on PCR in combination wit
h denaturing gradient gel electrophoresis (DGGE) for mutation scanning
of the entire coding sequence and all exon/intron boundaries of the P
AH. Systematic application of this method to the study of a large numb
er of mutant chromosomes from hyperphenylalaninemic patients demonstra
ted a 98% diagnostic efficiency and a 100% mutation detection efficien
cy. We have created compromised PCR and DGGE conditions for simultaneo
us amplification and simultaneous mutation scanning of all PAH-coding
fragments. This technique is convenient in a diagnostic setting and al
lows ''same-day'' DNA-based diagnosis of newborns with hyperphenylalan
inemia. A further modification of the method allows unambiguous identi
fication of known mutations, circumventing the cumbersome step of nucl
eotide sequencing.